Literature DB >> 1433581

Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long-term antibacterial prophylaxis. The International Reflux Study in Children.

U Jodal, O Koskimies, E Hanson, G Löhr, H Olbing, J Smellie, T Tamminen-Möbius.   

Abstract

A total of 306 children with grade III to IV vesicoureteral reflux (international classification) and a history of documented urinary tract infection was randomized into medical (155 patients) or surgical (151 patients) treatment arms in the European portion of the International Reflux Study in Children. Children treated medically were maintained on prophylactic antibacterials as long as the reflux persisted, while those treated surgically were covered prophylactically until followup studies at 6 months postoperatively demonstrated the reflux to be corrected. Standard definitions for bacteriuria were used, and the distinction was made clinically among acute pyelonephritis, cystitis and asymptomatic bacteriuria, supported in many instances by additional laboratory testing. Urine was cultured after 3 months and whenever suspicious symptoms occurred. Urinary tract infections developed during the first 5-year followup period in 59 patients (38%) in the medical group and in 59 (39%) in the surgical group but the incidence of pyelonephritis was higher in the medical group (21%) than in the surgical group (10%) (p < 0.01). Pyelonephritis often followed catheterization or cystoscopy but asymptomatic bacteriuria was uncommon after these procedures in either group. Recurrent infections were related to age, sex and treatment center. They were common in boys and girls entering under 1 year of age but were less common in girls and rare in boys entering after 1 year of age. Recurrences were lowest among the Finnish children and highest in the German and Belgian children.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433581     DOI: 10.1016/s0022-5347(17)36994-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

Review 1.  Antimicrobial prophylaxis.

Authors:  J Smith; A Finn
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

2.  Endoscopic treatment of vesicoureteral reflux: current practice and the need for multifactorial assessment.

Authors:  Göran Läckgren; Arne Stenberg
Journal:  Ther Adv Urol       Date:  2009-08

Review 3.  Urinary tract infection in children.

Authors:  James Larcombe
Journal:  BMJ Clin Evid       Date:  2010-02-09

4.  Postoperative medium-term follow-up of patients with bilateral, massive primary vesicorenal reflux and reduced renal function at presentation.

Authors:  G Belloli; G Bolla; F Cappellari; L Musi
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

5.  Ten-year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children.

Authors:  Ulf Jodal; Jean M Smellie; Hildegard Lax; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2006-03-25       Impact factor: 3.714

6.  Re.: J. Winberg: Management of primary vesico-ureteric reflux in children--operation ineffective in preventing progress of renal damage (Infection 22 [1994] S4-S7)

Authors:  H Olbing; T Tamminen-Möbius; U Jodal; J Smellie
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

7.  Subureteral collagen injection versus antireflux surgery in primary vesico-ureteral reflux grade III.

Authors:  N Gordjani; A Frankenschmidt; L B Zimmerhackl; M Brandis
Journal:  Eur J Pediatr       Date:  1996-06       Impact factor: 3.183

8.  Gender and vesico-ureteral reflux: a multivariate analysis.

Authors:  Jose Maria Penido Silva; Eduardo Araujo Oliveira; Jose Silverio Santos Diniz; Luis Sergio Bahia Cardoso; Renata Moura Vergara; Mariana Affonso Vasconcelos; Daniela Espirito Santo
Journal:  Pediatr Nephrol       Date:  2006-03-14       Impact factor: 3.714

Review 9.  Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled trials.

Authors:  D Wheeler; D Vimalachandra; E M Hodson; L P Roy; G Smith; J C Craig
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

10.  Antibiotic prophylaxis in pediatric urology.

Authors:  Seung-Hun Song; Kun Suk Kim
Journal:  Indian J Urol       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.